I tested Megelin red light therapy for 30 days — I (and my body) have thoughts
The author tested Megelin's red light therapy and EMS devices over 30 days to evaluate their effectiveness for at-home wellness. Red light therapy, or photobiomodulation, aims to boost cellular energy and repair, while EMS stimulates muscle contractions through electrical impulses. The review explores whether the brand delivers on its scientific claims or simply capitalizes on wellness trends.
- ▪Megelin combines red light therapy and EMS technology to offer at-home treatments for muscle recovery and skin health.
- ▪Red light therapy works by stimulating mitochondria to produce more ATP, which can reduce inflammation and promote collagen production.
- ▪EMS sends electrical impulses to motor neurons, causing muscle contractions that can improve strength and combat muscle atrophy.
- ▪Clinical studies suggest consistent use of red light therapy can reduce skin inflammation by nearly 45%.
- ▪The devices are designed for passive use, allowing integration into daily activities like working or browsing online.
Opening excerpt (first ~120 words) tap to expand
Shopping I tested Megelin red light therapy for 30 days — I (and my body) have thoughts By Kendall Cornish Published May 16, 2026, 10:30 a.m. ET New York Post Composite New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. I’ve reached a delightful era of my life wherein I’m regularly arrested by my lower back for the crime of working at a desk. My face has begun to resemble a topographical map of my poorest life choices (cigarettes, acne-picking and lack of sunscreen). Naturally, when the internet started raving about Megelin, a brand pledging to treat biological woes at home with the modern medspa science of EMS and light therapies, I wanted to know if the substance matched the hype.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
